Status:

UNKNOWN

Clinical Study Assessing the Effect of ZIVEREL® in Cancer Patients

Lead Sponsor:

Grupo de Investigación Clínica en Oncología Radioterapia

Collaborating Sponsors:

Norgine

Conditions:

Acute Esophagitis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Radiation-induced esophagitis is an acute, dose-limiting toxicity in oncologic treatment. Since it can lead to interruption of treatment, hospitalization, and even death, clinicians should be aware of...

Detailed Description

Hyaluronic acid is a glycosaminoglycan formed by glucuronic acid and N acetylglucosamine disaccharide units. It is found mainly in the extracellular matrix of the loose connective tissue and is associ...

Eligibility Criteria

Inclusion

  • ECOG PS 0-1.
  • Signature of informed consent.
  • Patients with any type of neoplasm that requires treatment with radiotherapy or radiochemotherapy, and who develop a radiation-induced esophagitis of degree ≥ 2 (according to CTCAE v4.03)
  • Hematological function (neutrophils ≥2000 / ml, platelets ≥100000 / ml, hemoglobin\> gr / dl), hepatic (bilirubin \<1.5) and renal acceptable (glomerular filtration rate\> 50 ml / min).
  • Patients without contraindication for the administration of ZIVEREL®, in accordance with the instructions for use of the product.

Exclusion

  • ECOGPS≥2
  • Hypersensitivity for some of the active ingredients or a component of ZIVEREL®
  • Alteration in haematological function (neutrophils ≤2000 / ml, platelets ≤100000 / ml, hemoglobin \<8gr/dl), hepatic (bilirubin\> 1.5) and/or glomerular filtration rate \<50 ml/min).
  • Patients who have a medical history of psychiatric disorders or any other condition that interfere with the study
  • Patients with esophageal candidiasis or oral cavity candidiasis at the time of entry into the study.

Key Trial Info

Start Date :

June 15 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2023

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04070677

Start Date

June 15 2019

End Date

June 30 2023

Last Update

August 5 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Universitario Ramón y Cajal

Madrid, Spain, 28034

Clinical Study Assessing the Effect of ZIVEREL® in Cancer Patients | DecenTrialz